Latest serological survey conducted in Delhi revealed one in three or 33% of the population has developed antibodies against coronavirus.…
Results of the first serological surveillance study conducted in city of Pune reveal that 51.5% of surveyed population has developed…
A portion of people who had applied to enroll for AIIMS coronavirus vaccine trial for India’s first indigenous vaccine, Covaxin…
This website uses cookies.
Read More